06/11/2021

FDA Asks J&J to Discard 60 Million Vaccine Doses

The doses were manufactured at a troubled plant in Baltimore

The U.S. Food & Drug Administration (FDA) has asked Johnson & Johnson (J&J) to discard 60 million doses of its COVID-19 vaccine manufactured at the problem-plagued Baltimore factory, The New York Times reported on Friday, citing people familiar with the matter.

A further 10 million J&J doses would be allowed to be distributed with a warning that there was no guarantee contract manufacturer Emergent BioSolutions Inc (EBS.N) had followed proper practices, the newspaper said.

The FDA said in a news release that it had agreed that two batches of the vaccine were authorized for use, but that multiple other batches were not suitable for use and that others were being evaluated.

Please select this link to read the complete article from Reuters.